semaglutide weight loss maryland Medical GLP-1 in (MD) Semaglutide GLP-1 Treatment Specialist |
Description
Promising new modalities exist to diagnose gastroparesis and whole-gut motility disturbances, such as electrogastrography and wireless motility capsules, which may become more widely used provided they are covered by insurance and FDA-cleared, respectively
Such studies should incorporate systematic assessment of total, bioavailable, and free testosterone levels, as well as estradiol, during pharmacologically induced weight loss in order to clarify whether normalization of the endocrine milieu mitigates lean mass decline
Zhang B
Sperling et al
At the end of the day, the proposal is about the line between access and oversight
PMCID: PMC8619199
